– Reuters Citing Conference Call
Paratek Pharmaceuticals Announces Modification Of BARDA Contract To Advance The Development Of NUZYRA For Post-Exposure Prophylaxis And Treatment Of Pulmonary Anthrax
-- Third procurement to be split into two procurements based on the achievement of specific anthrax development milestones
-- Next procurement expected in early 2024
BOSTON, July 10, 2023 (GLOBE NEWSWIRE)